36 Results for "

Vascular endothelial growth factor C

" in MedChemExpress (MCE) Product Catalog:
Products (36)

36 Results for "Vascular endothelial growth factor C" in MCE Product Catalog:

7
7 Cited Publications
Cat. No.: HY-P74474
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFC; Vascular endothelial growth factor C; Vascular endothelial growth factor-Related Protein; VRP; VEGF-C; Flt4 Ligand; Flt4-L; FLT4 Ligand DHM; LMPH1D; LMPHM4
Species:  
Mouse Rat
Source:  
HEK293
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10408
CAS No.: 623142-96-1
Purity:  99.51%
Target:  

c-Fms VEGFR c-Kit PDGFR

Research Areas:  

Inflammation/Immunology

Ki20227 is an orally active and highly selective c-Fms tyrosine kinase (CSF1R) inhibitor with IC50s of 2 nM, 12 nM, 451 and 217 nM for CSF1R, VEGFR2 (vascular endothelial growth factor receptor-2), c-Kit (stem cell factor receptor) and PDGFRβ (platelet-derived growth factor receptor β). Ki20227 suppresses osteoclast differentiation and osteolytic bone destruction .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-P7313
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFC; Vascular endothelial growth factor C; Vascular endothelial growth factor-Related Protein; VRP; VEGF-C; Flt4 Ligand; Flt4-L; FLT4 Ligand DHM; LMPH1D; LMPHM4
Species:  
Human
Source:  
HEK293
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N0249
CAS No.: 20736-08-7
Saikosaponin C is an orally active MMP-2 inducer. Saikosaponin C induces the survival, growth, migration and capillary tube formation of endothelial cells. Saikosaponin C inhibits the early stage of hepatitis C virus infection. Saikosaponin C can be used in research related to ischemic tissue diseases, chronic kidney diseases and hepatitis C virus infection .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P70458A
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular endothelial growth factor A; VEGF; VPF; Vascular Permeability factor; Vascular endothelial growth factor A, Long Form; VEGF-A; L-VEGF; Vascular endothelial growth factor A121; Vascular endothelial growth factor A165; Vascular endothelial growth factor; VEGFA Protein; MVCD1
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-13718
CAS No.: 38101-59-6
Purity:  98.97%
Synonyms: H-Glu-Trp-OH; L-Glutamyl-L-tryptophan
Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus. Oglufanide inhibits vascular endothelial growth factor (VEGF). Oglufanide can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide shows antitumor and anti-angiogenesis activities .
loading...
    loading...
Cat. No.: HY-18711
CAS No.: 1174161-69-3
Synonyms: Metatinib free base; c-Met inhibitor 2 free base
Target:  

c-Met/HGFR VEGFR

Research Areas:  

Cancer

SCR-1481B1 free base, also known as Metatinib free base, is a small molecule receptor kinase inhibitor that targets both c-MET and vascular endothelial growth factor receptor 2 (VEGFR2) .
loading...
    loading...
Cat. No.: HY-177134
CAS No.: 2243235-80-3
Target:  

VEGFR c-Met/HGFR

Research Areas:  

Cancer

Taligantinib (Compound Example 70) is an orally active and selective dual inhibitor targeting vascular endothelial growth factor receptor 2 (VEGFR-2) and hepatocyte growth factor receptor (c-Met). Taligantinib suppresses tumor angiogenesis and cell proliferation. Taligantinib is promising for research of solid tumors such as non-small cell lung cancer and hepatocellular carcinoma .
loading...
    loading...
Cat. No.: HY-10338A
CAS No.: 1226999-07-0
Target:  

c-Met/HGFR VEGFR

Research Areas:  

Cancer

Foretinib phosphate is an orally bioavailable small molecule with potential anti-tumor activity. Foretinib phosphate can selectively inhibit hepatocyte growth factor (HGF) receptor c-MET and vascular endothelial growth factor receptor 2 (VEGFR2), thereby potentially inhibiting tumor angiogenesis, tumor cell proliferation and metastasis. Foretinib phosphate shows different anti-cancer activity from cabozantinib in lung cancer cells and has stronger inhibitory effects on targets such as MEK1/2, FER and AURKB .
loading...
    loading...
Cat. No.: HY-P10833
Target:  

VEGFR PI3K Akt mTOR ERK Apoptosis

Research Areas:  

Cardiovascular Disease Cancer

C-VGB3 is a selective vascular endothelial growth factor receptor 2 (VEGFR2) antagonist, which inhibits VEGFR2-mediated PI3K/AKT/mTOR and PLCγ/ERK1/2 signaling pathways. C-VGB3 binds to the extracellular domain of VEGFR2, blocking ligand-receptor interaction and inducing apoptosis in endothelial and tumor cells through both intrinsic (involving Bcl2 family and caspases) and extrinsic (death receptor-mediated) pathways. C-VGB3 is promising for research of angiogenesis-related cancers, such as breast cancer .
loading...
    loading...
Cat. No.: HY-174507
Target:  

mRNA

Research Areas:  

Cancer

Human VEGFD mRNA encodes the human vascular endothelial growth factor D (VEGFD) protein, a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. VEGFD is structurally and functionally similar to vascular endothelial growth factor C (VEGFC).
loading...
    loading...
Cat. No.: HY-174508
Target:  

mRNA

Research Areas:  

Cancer

Human VEGFC mRNA encodes the human vascular endothelial growth factor C (VEGFC) protein, a member of the platelet-derived growth factor/vascular endothelial growth factor (PDGF/VEGF) family. VEGFC promotes angiogenesis and endothelial cell growth, and can also affect the permeability of blood vessels.
loading...
    loading...
Cat. No.: HY-13718A
CAS No.: 237068-57-4
Synonyms: H-Glu-Trp-OH disodium; L-Glutamyl-L-tryptophan disodium
Oglufanide (H-Glu-Trp-OH) disodium is a dipeptide immunomodulator isolated from calf thymus. Oglufanide disodium inhibits vascular endothelial growth factor (VEGF). Oglufanide disodium can stimulate the immune response to hepatitic C virus (HCV) and intracellular bacterial infections. Oglufanide disodium shows antitumor and anti-angiogenesis activities .
loading...
    loading...
Cat. No.: HY-15651S
Synonyms: AZD9668-13C,d3
Alvelestat- 13C,d3 (AZD9668- 13C,d3) is the deuterated, 13C-labeled Alvelestat (HY-15651). Alvelestat (AZD9668) is an orally active, selective inhibitor of neutrophil elastase. Alvelestat reduces elastase activity, myeloperoxidase release, neutrophil recruitment and activation, and calcium phosphate precipitation; promotes smooth muscle cell colonization and collagen deposition; and inhibits the formation of neutrophil extracellular traps (NETs) as well as NET-derived neutrophil elastase activity. Alvelestat restores endothelial dysfunction, regulates antioxidant factors, improves the expression of endothelial tight junctions, reduces vascular leakage, and accelerates wound healing. Alvelestat prevents pulmonary hemorrhage, matrix protein degradation, airspace enlargement, and small airway wall remodeling; and alleviates cigarette-induced inflammatory responses. Alvelestat inhibits the growth of abdominal aortic aneurysms exacerbated by Porphyromonas gingivalis. Alvelestat can be used in research related to chronic obstructive pulmonary disease, abdominal aortic aneurysm, radiation-induced skin injury, and bronchiectasis .
loading...
    loading...
Cat. No.: HY-15334
CAS No.: 402857-39-0
Target:  

VEGFR

Research Areas:  

Cancer

CEP-5214, derived from a new indenopyrrolocarbazole template, is a potent inhibitor of vascular endothelial growth factor R2 (VEGF-R2) tyrosine kinase. Structurally, it features optimal substitutions at positions 9 (ethoxymethyl) and 12 (hydroxypropyl) on the indeno[2,1-a]pyrrolo[3,4-c]carbazole-5-one scaffold, leading to high potency against VEGF-R2 (IC50 8 nM). Compound 21 (CEP-5214) exhibits low-nanomolar inhibition of human VEGF-R tyrosine kinases (IC50 4 nM for VEGF-R2/KDR), with good selectivity over other kinases. The compound demonstrated significant cellular and in vivo antitumor activity across various models and advanced into phase I clinical trials as a water-soluble prodrug (CEP-7055) to enhance oral bioavailability .
loading...
    loading...
Cat. No.: HY-P74475
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFC; Vascular endothelial growth factor C; Vascular endothelial growth factor-Related Protein; VRP; VEGF-C; Flt4 Ligand; Flt4-L; FLT4 Ligand DHM; LMPH1D; LMPHM4
Species:  
Rat Mouse
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P70501
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFC; Vascular endothelial growth factor C; Vascular endothelial growth factor-Related Protein; VRP; VEGF-C; Flt4 Ligand; Flt4-L; FLT4 Ligand DHM; LMPH1D; LMPHM4
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P73529
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFC; Vascular endothelial growth factor C; Vascular endothelial growth factor-Related Protein; VRP; VEGF-C; Flt4 Ligand; Flt4-L; FLT4 Ligand DHM; LMPH1D; LMPHM4
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P706195
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFA; Vascular endothelial growth factor A; VEGF; VPF; Vascular Permeability factor; Vascular endothelial growth factor A, Long Form; VEGF-A; L-VEGF; Vascular endothelial growth factor A121; Vascular endothelial growth factor A165; Vascular endothelial growth factor; VEGFA Protein; MVCD1
Species:  
Human
Source:  
HEK293
loading...
    loading...
Cat. No.: HY-P7314
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: VEGFD; Vascular endothelial growth factor D; FIGF; VEGF-D; C-Fos Induced growth factor (Vascular endothelial growth factor D); C-Fos-Induced growth factor
Species:  
Human
Source:  
CHO
loading...
    loading...